Cubist Systematic Strategies, LLC Seelos Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $14.3 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.66 - $1.22 $15,927 - $29,441
24,132 New
24,132 $28,000
Q4 2021

Feb 14, 2022
SELL
$1.59 - $2.38 $283,838 - $424,865
-178,515 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$1.69 - $2.89 $31,290 - $53,508
18,515 Added 11.57%
178,515 $430,000
Q2 2021

Aug 16, 2021
BUY
$2.64 - $6.32 $282,480 - $676,240
107,000 Added 201.89%
160,000 $422,000
Q1 2021

May 17, 2021
BUY
$1.35 - $4.99 $71,550 - $264,470
53,000 New
53,000 $264,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0
View Full List

About SEELOS THERAPEUTICS, INC.

SEEL Quotes by TradingView
  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $117M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email